

Jasmine Okandeji is a dedicated Biomedical Scientist with a strong commitment to continuous learning and professional growth. She is passionate about contributing to the pharmaceutical, biotechnology, and medical device industries through the application of her skills in bioanalytical assays, clinical research, and development. Jasmine is highly adaptable, a fast learner, and brings valuable insights into team environments. Her ability to quickly grasp new concepts makes her well-suited for cross-training across multiple areas of specialization.
Project Summary:
This project investigated the therapeutic effects of Crassocephalum rubens on hepatic damage induced by DMBA. A crude extract of C. rubens was administered to the affected rats over a 10-week period, and the results were systematically documented. The study was published on July 30, 2024, in the Tropical Journal of Natural Product Research (TJNPR).
Project Summary:
This project investigated an effective approach for delivering a natural anticancer therapy in vivo. Gold(III) chloride trihydrate and Crassocephalum rubens, a medicinal plant with reported anticancer properties, were used to biosynthesize gold nanoparticles. The nanoparticles were then evaluated for their therapeutic potential in cancer-induced rats.
Project Summary:
This research is based on the use of digital polymerase chain reaction in diagnosing cancer due to its high specificity that allows it to detect the slightest change in the human DNA sequence thereby allowing medical practitioners to detect cancer at an early stage where surgical removal is still possible.